Golden
Codagenix

Codagenix

Codagenix is a biotechnology company developing live attenuated vaccines.

All edits

Edits on 9 Jul 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 9 Jul 2019 2:49 pm
Edits made to:
Infobox (+1 properties)
Edits on 5 Mar 2019
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 5 Mar 2019 2:47 am
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 22 Feb 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 22 Feb 2019 8:14 pm
Edits made to:
Article (+21/-21 characters)

Article

Codagenix is a privately held, biotechnology company based in Stony Brook, New YorkStony Brook, New York. The company focuses on constructing live-attenuated viral vaccines against multiple targets using the company's proprietary technology platform, SAVE. Standing for Synthetic Attenuated Virus Engineering, the platform relies on synthetic biology and the rational 're-design' of a target virus' entire genome to yield a vaccine strain. The customization process uses software-based algorithms to 're-code' the genome of a target virus. 

Edits on 14 Feb 2019
Rebecca Hammond
Rebecca Hammond approved a suggestion from Golden's AI on 14 Feb 2019 2:42 pm
Edits made to:
Infobox (+3 properties)
People (+2 cells) (+19 characters)

People

Name
Role
Related Golden topics

Rishab Kaul

Employee



Infobox

Edits on 12 Feb 2019
Sameeha Sulaiman
Sameeha Sulaiman edited on 12 Feb 2019 1:05 pm
Edits made to:
Further reading (-8 cells) (-603 characters)

Further reading

Title
Author
Link
Type

Codagenix A Tiny Start-Up Ready To Take On The Goliaths Of The Vaccine Industry



Web

Codagenix Inc. Receives Phase I SBIR Grant from US Department of Agriculture to Develop Swine Influenza Vaccine





RSV vaccine player Codagenix snags $3M in public and private investment | FiercePharma



Web

Sameeha Sulaiman
Sameeha Sulaiman edited on 12 Feb 2019 1:05 pm
Edits made to:
Infobox (+4 properties)
Article (+701 characters)
Further reading (+11 cells) (+782 characters)

Article



Codagenix is a privately held, biotechnology company based in Stony Brook, New York. The company focuses on constructing live-attenuated viral vaccines against multiple targets using the company's proprietary technology platform, SAVE. Standing for Synthetic Attenuated Virus Engineering, the platform relies on synthetic biology and the rational 're-design' of a target virus' entire genome to yield a vaccine strain. The customization process uses software-based algorithms to 're-code' the genome of a target virus. 



The company's product pipeline includes vaccines for influenza, respiratory syncytial virus (RSV), dengue, foot and mouth disease virus (FMDV), pathogenic E. Coli, and other targets.

Further reading

Title
Author
Link
Type

Codagenix A Tiny Start-Up Ready To Take On The Goliaths Of The Vaccine Industry



Web

Codagenix Inc. Receives Phase I SBIR Grant from US Department of Agriculture to Develop Swine Influenza Vaccine





RSV vaccine player Codagenix snags $3M in public and private investment | FiercePharma



Web

Xconomy: With $2M, Codagenix Becomes Accelerate LI's First VC-Backed Grad



Web

Infobox

Edits on 4 Jan 2019
Sameeha Sulaiman
Sameeha Sulaiman edited on 4 Jan 2019 3:28 pm
Edits made to:
Description (+57 characters)
People (+6 cells) (+149 characters)
Topic thumbnail

Codagenix

Biotechnology company developing live attenuated vaccines

People

Name
Role
Related Golden topics

Eckard Wimmer

Co-Founder, Senior Scientific Officer



J. Robert Coleman

Co-Founder & COO



Steffen Mueller

Co-Founder, President, and Chief Scientific Officer



Edits on 21 Apr 2018
Melanie Manipula
Melanie Manipula edited on 21 Apr 2018 9:30 pm
Edits made to:
Topic thumbnail

Codagenix

Biotechnology company developing live attenuated vaccines

Melanie Manipula"Initial topic creation"
Melanie Manipula created this topic on 21 Apr 2018 9:03 pm
Edits made to:
Description
Academic papers
People
Further reading
Documentaries, videos and podcasts
Companies
Products
Topic thumbnail

 Codagenix

Biotechnology company developing live attenuated vaccines

No more activity to show.